Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4???-hydroxylation activities in livers of Japanese and Caucasian populations-Reference-Cited by-同舟云学术

Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4???-hydroxylation activities in livers of Japanese and Caucasian populations

Published:1997-04 Issue:2 Volume:7 Page:103-113
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Inoue Kiyoshi,Yamazaki Hiroshi,Imiya Kimiyuki,Akasaka Susumu,Guengerich F Peter,Shimada Tsutomu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database;Biological and Pharmaceutical Bulletin;2024-05-24

2. Modeled Hepatic/Plasma Exposures of Fluvastatin Prescribed Alone in Subjects with Impaired Cytochrome <i>P450 2C9*3</i> as One of Possible Determinant Factors Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database;Biological and Pharmaceutical Bulletin;2024-03-15

3. A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity;Pharmacology Research & Perspectives;2022-03-20

4. Metabolizer phenotype prediction in different Peruvian ethnic groups through CYP2C9 polymorphisms;Drug Metabolism and Personalized Therapy;2021-03-18

5. Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis;European Journal of Drug Metabolism and Pharmacokinetics;2020-12-26